Phase 3: Advanced Integration, Multimodality Correlation and Safe Practice
What Phase 3 tests
Phase 3 is about integrating modalities, weighing risk, and communicating uncertainty - the behaviours of a consultant. Concepts to name: staging principles (TNM logic, why size thresholds differ by organ), response assessment (RECIST-style measurement discipline, pseudoprogression), and the role of MDT discussion. You must understand modality selection under constraint: radiation risk in pregnancy and children, contrast allergy and renal impairment, MRI safety zoning, and the limitations of each test (CT for early infarct, ultrasound for deep structures, MRI for calcification). Know the emergencies where the report changes management: aortic dissection, pulmonary embolism, bowel ischaemia, tension pneumothorax, cord compression, and acute limb ischaemia. Cross-sectional anatomy at a level sufficient to localise a lesion to a segment or compartment is expected.
Traps
Questions test whether you over-investigate: a classic benign-looking lesion does not need biopsy. They also test communication - the answer may be 'discuss at MDT' or 'recommend interval imaging' rather than immediate surgery. Watch for stems where a contrast-enhanced study is contraindicated and a non-contrast alternative exists. Finally, beware absolute language ('always', 'never') in options; radiology answers are usually conditional.
Rule of thumb
Ask three questions for every case: does this finding change management, what is the safest test that answers it, and who needs to know now? Worked example: a 68-year-old with jaundice and a pancreatic head mass - the correct pathway is multiphase pancreatic-protocol CT for staging, with tissue confirmation only if it alters treatment; do not jump to biopsy before staging.